The backlash against bioequivalence and the interchangeability of brand-name and generic drugs

類似資料

• Medicare Formulary Coverage of Brand-Name Drugs and Therapeutically Interchangeable Generics
  著者:: Vijay, Aishwarya, 等
  出版事項: (2019)
• The Case for Reforming Drug Naming: Should Brand Name Trademark Protections Expire upon Generic Entry?
  著者:: Sarpatwari, Ameet, 等
  出版事項: (2016)
• Quality of Reporting of Bioequivalence Trials Comparing Generic to Brand Name Drugs: A Methodological Systematic Review
  著者:: van der Meersch, Amélie, 等
  出版事項: (2011)
• Brand and generic medications: Are they interchangeable?
  著者:: Al-Jazairi, Abdulrazaq S., 等
  出版事項: (2008)
• The concept of: Generic drugs and patented drugs vs. brand name drugs and non-proprietary (generic) name drugs
  著者:: Thakkar, Karan B., 等
  出版事項: (2013)